Discrepancies between in vivo and in vitro effects of glucorticoids in myelomonocytic leukemic cells with steroid receptors.
D001667:Binding, Competitive; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005938:Glucocorticoids / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D007958:Leukocyte Count; D008297:Male; D009363:Neoplasm Proteins / Q000096:biosynthesis; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D011987:Receptors, Steroid / Q000378:metabolism; D013256:Steroids / Q000378:metabolism; D014222:Triamcinolone Acetonide / Q000378:metabolism
D004273:DNA, Neoplasm; D005938:Glucocorticoids; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D011965:Receptors, Glucocorticoid; D011987:Receptors, Steroid; D013256:Steroids; D014222:Triamcinolone Acetonide